PROCEPT BioRobotics (PRCT) Interest Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Interest Expenses data on file, last reported at $35.4 million in Q1 2026.

• On a quarterly basis, Interest Expenses fell 10.9% year-over-year to $35.4 million in Q1 2026; TTM through Mar 2026 was $35.4 million, a 10.9% decrease from a year earlier, with the FY2025 full-year figure at $183.0 million, up 17.19% from the prior year.
• Interest Expenses for Q1 2026 stood at $35.4 million, up from $1.6 million in the prior quarter.
• Over the last five years, Interest Expenses for PRCT reached as high as $49.6 million in Q1 2023 and fell as low as -$1.1 million in Q4 2022.
• Historically, Interest Expenses has averaged $16.5 million across 5 years, with a median of $12.6 million in 2024.
• Across the five-year window, Interest Expenses tumbled 174.17% in 2022 and soared 1178.28% in 2023, its largest moves.
• Year by year, Interest Expenses stood at -$1.1 million in 2022, then jumped by 205.34% to $1.1 million in 2023, then retreated by 14.93% to $957000.0 in 2024, then surged by 67.71% to $1.6 million in 2025, then surged by 2104.17% to $35.4 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $35.4 million in Q1 2026, $1.6 million in Q4 2025, and $37.6 million in Q3 2025.